What does the extra disulfide bond in rabbit kappa light chains actually do?
Why this paper exists
“Rabbit antibodies are better” is said often and explained rarely. The usual reasons given — broader epitope repertoire, higher affinity, tolerance of human self-antigens — are about the immune system, not about the molecule. This study asks a narrower question with a measurable answer: rabbit kappa chains have a structural feature that mouse and human kappa chains lack, so what is it for?
The feature is an inter-domain disulfide bond between the variable and constant domains of the kappa light chain. The experiment was to remove it and measure what changed.
The result, stated plainly
That is a cleaner separation than one usually gets. In most antibody engineering, stability and affinity are entangled — you gain one and pay for it in the other. Here is a case where nature has provided a stability feature that is essentially free with respect to binding, and it is present by default in the rabbit repertoire.
Why it matters commercially
- It is a real answer to “why rabbit?” When a sponsor asks what they are actually buying by choosing a rabbit platform over a mouse one, this is a structural, measured answer rather than a marketing claim.
- It suggests a general engineering strategy. The authors note the finding “would give suggestions for the methods to artificially stabilize antibody molecules” — that is, an engineered inter-domain disulfide is a candidate stabilisation route for antibodies that do not have one naturally.
- It explains a technical obstacle we had to solve. This same extra cysteine architecture is why rabbit Fabs historically would not express in E. coli, and why earlier rabbit phage-display systems were limited to the underused Cκ2 chain instead of the Cκ1 chain that dominates the serum response. The feature that makes rabbit antibodies stable is the feature that made them hard to display.
Our phagemid vector was built specifically to display fully rabbit Fabs including the Cκ1 chain, so the campaign draws on the whole repertoire rather than a fraction of it. That is described in more detail on the rabbit monoclonal discovery page.
Deciding between rabbit and another platform?
Tell us the target and the assay it has to work in, and we will tell you whether rabbit is actually the right starting point — including when it is not. A PhD scientist replies within two business days.
Talk to a scientist →Frequently asked questions
Do all rabbit antibodies have this disulfide bond?
It is a feature of rabbit kappa light chains, which account for the large majority of the rabbit antibody response. It is not present in mouse or human kappa chains.
If I humanize a rabbit antibody, do I lose the stability?
You lose that particular structural feature, since human kappa chains do not carry it. Whether measured stability drops depends on the clone, which is why thermostability is part of what we characterise during humanization rather than something we assume. If it becomes limiting it can be engineered back.
Can you add an inter-domain disulfide to an antibody that lacks one?
Engineered disulfides are a recognised stabilisation strategy and this paper is part of the rationale for it. Whether it works on a given molecule has to be tested — introduced cysteines can also cause mispairing and expression problems, so it is one option among several in a thermostability campaign.
Does the extra cysteine cause manufacturing problems?
It caused display problems historically, in bacterial expression of rabbit Fabs. In mammalian expression of full-length IgG it is the native architecture and behaves as such.
Is rabbit always the right choice?
No. Rabbit is the stronger starting point for small molecules, phospho-sites, human self-antigens and applications needing picomolar affinity. For some targets and some formats another route is better, and we will say so.
Want this run on your target?
The stability advantage described here is something we select for directly rather than rely on. These are the campaigns that use it.
- Thermostability engineering — heat-challenge selection between panning rounds, with binding held constant
- Rabbit monoclonal discovery (RabWiz™) — de novo rabbit mAbs from immune phage libraries
- Developability optimization — aggregation, viscosity, sequence liabilities and polyreactivity
Every campaign is scoped individually and quoted. Email info@abwizbio.com with your target or lead sequence, or see all 25 publications and the full service menu.